Journal profile · HEMATOLOGY
eJHaem
ISSN 2688-6146 · Wiley · United Kingdom
eJHaem: CAS Zone 4 · Medicine (2026 Xinrui edition); impact factor 1.3 (journal website); fully open access; APC about USD 3,150; median 73 days to acceptance (110 articles, last 24 months); acceptance rate 46% (journal website); 249 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
eJHaem is published by Wiley and is classed under Medicine in the CAS Journal Ranking. By OpenAlex counts of its recent articles, its largest topics are Lymphoma Diagnosis and Treatment, Acute Myeloid Leukemia Research and Multiple Myeloma Research and Treatments, together about 28.2% of its articles. Its main subfields are Hematology and Genetics. (generated from OpenAlex topic counts and CAS ranking data)
eJHaem is an Open Access (OA) journal owned by Wiley and the British Society for Haematology publishing high-quality original articles covering a broad array of haematology topics. The journal accepts direct submissions as well as content that is cascaded from the top quartile journals British Journal of Haematology and American Journal of Hematology. Haematology topics of interest for the journal include clinical and translational research in the epidemiology, etiology, diagnosis, prognosis, and novel therapeutic advances in plasma cell neoplasms, myeloproliferative neoplasms, lymphoid and myeloid malignancies, and benign haematology. In addition, submission of longer articles and publications with novel formatting will be encouraged as will burgeoning areas of interest such as “real world evidence”, “decision making”, “health economics”, “immune effector cell therapies”, “biomarker discovery”, and other impactful translational topics. Furthermore, eJHaem will publish haematology topics representing including areas of research in under-represented regions of the world and unique translational research fields (e.g., bio-engineering; systems biology; big data; comparative oncology; etc). Articles reporting clinical trials that will ultimately improve the design of targeted therapies and contribute to improved patient treatment are of high interest. Methods papers will also be considered. eJHaem is a Gold OA, sound science, journal. The OA, electronic only format enables the journal to nimbly and quickly publish key advances in the field of haematology. This will include the ability to harness medium of rapid and novel information dissemination such as use of podcasts, video blogs, and other innovative methods of audio and video broadcast. The journal will also cultivate an awareness of new trends to maintain openness to unique scientific concepts that emerge. Indexing Information CAS: Chemical Abstracts Service (ACS) Directory of Open Access Journals (DOAJ) Embase (Elsevier) Emerging Sources Citation Index (Clarivate Analytics) OneFile: Health and Medicine (GALE Cengage) OneFile: Nursing and Allied Health (GALE Cengage) PubMed (NLM) Web of Science (Clarivate Analytics) eJHaem deposits all articles in PMC (PubMed Central).
From the journal's Aims & Scope
Research area (LetPub): HEMATOLOGY
Editor-in-chief Phil ScheinbergPublisher website
Editorial board by country: none in mainland China; most named United Kingdom 5, United States 2, France 2, Israel 2, Italy 1 (18 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Lymphoma Diagnosis and TreatmentMedicine10.4%
- Acute Myeloid Leukemia ResearchMedicine9.6%
- Multiple Myeloma Research and TreatmentsMedicine8.2%
- Chronic Lymphocytic Leukemia ResearchMedicine8%
- Myeloproliferative Neoplasms: Diagnosis and TreatmentMedicine5.7%
- Hemoglobinopathies and Related DisordersMedicine5.7%
- Chronic Myeloid Leukemia TreatmentsMedicine5.1%
- Acute Lymphoblastic Leukemia researchMedicine4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCPubMedEmbaseCASPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 1.3Publisher website ·
- Impact factor (publisher) 2025
- 1.3Publisher website ·
- h-index
- 23OpenAlex ·
- i10-index
- 141OpenAlex ·
- 2-year mean citedness
- 1.32OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 196LetPub ·
- Articles per year (publisher) 2025
- 227Publisher website ·
- Downloads per year (publisher) 2025
- 320,206Publisher website ·
Articles by year OpenAlex count · 1,517 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 199 | 199 | 29 |
| 2025 | 249 | 249 | 253 |
| 2024 | 240 | 240 | 628 |
| 2023 | 201 | 201 | 921 |
| 2022 | 265 | 265 | 1,227 |
| 2021 | 217 | 217 | 1,661 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
73 daysMedian, submission to acceptance · P25–P75 45 days – 114 days
- Acceptance to online
- median 28 days (110 articles)
- Submission to online
- median 105 days
- Sample
- 110 articles with submission and acceptance dates (488 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 8 weeksLetPub ·
- Acceptance rate (publisher)
- 46%Publisher website ·
- Acceptance rate (publisher) 2025
- 46%Publisher website ·
- Submission to first decision
- 7 daysPublisher website ·
- Submission to first decision 2025
- 27 daysPublisher website ·
- Submission to final decision
- 26 daysPublisher website ·
- Submission to acceptance 2025
- 82 daysPublisher website ·
- Acceptance to publication 2025
- 32 daysPublisher website ·
- Submission to publication (journal-reported)
- about 8 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 3,150 / GBP 2,460 / EUR 2,800 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 2,860 / EUR 2,540 / GBP 2,230 | — | — | |
| LetPub | USD 2,480 / GBP 1,930 / EUR 2,200 | Yes | — | |
| Publisher website | No APC | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted9
- case reportArticle Type Description Word Limit Abstract / Structure Research Article Reports of new research findings or conceptual analyses that make a significant contri…Length not stated
- commentaryArticle Type Description Word Limit Abstract / Structure Research Article Reports of new research findings or conceptual analyses that make a significant contri…Length not stated
- correspondenceArticle Type Description Word Limit Abstract / Structure Research Article Reports of new research findings or conceptual analyses that make a significant contri…Length not stated
- editorialArticle Type Description Word Limit Abstract / Structure Research Article Reports of new research findings or conceptual analyses that make a significant contri…Length not stated
- haematology imagesHaematology Images An illustration (or, where appropriate, two or more related images) which is interesting, instructive and visually attractive, with a few lin…Length not stated
- letterArticle Type Description Word Limit Abstract / Structure Research Article Reports of new research findings or conceptual analyses that make a significant contri…Length not stated
- research articleArticle Type Description Word Limit Abstract / Structure Research Article Reports of new research findings or conceptual analyses that make a significant contri…Length not stated
- reviewArticle Type Description Word Limit Abstract / Structure Research Article Reports of new research findings or conceptual analyses that make a significant contri…Length not stated
- short reportShort Report Preliminary findings of research in progress or a case report of particular interest. Main body of text 1500 limit; abstract 100 words; references …Length not stated
Policy excerpts from the journal's websiteAuthorship, Data availability, License & copyright, Open access, Peer review, Preprints
- Authorship Authorship
All listed authors should have contributed to the manuscript substantially and have agreed to the final submitted version. Review our ethical standards and scroll down for a description of authorship criteria.
Source ↗Publisher website ·- Data availability Data Sharing and Data Availability
This journal encourages data sharing. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.
Source ↗Publisher website ·- License & copyright Reproduction of Copyright Material
If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is your responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ.
Source ↗Publisher website ·- Open access WALS + Full Open Access
ORCID required since January 2023. Model summary
eJHaem is an Open Access journal: authors of accepted papers pay an Article Publication Charge and their papers are published under a Creative Commons license. Authors have a choice of the CC BY, CC BY-NC, or CC BY-NC-ND Creative Commons License. Note that certain funders mandate a particular type of license be used. For more information on this journal’s APCs and licensing policy, please visit th…
Source ↗Publisher website ·- Peer review 1. Submission and Peer Review Process
Single-blind peer review with at least two anonymous reviewers. Model summary
Once the submission materials have been prepared in accordance with the Author Guidelines, manuscripts should be submitted online at https://authors.wiley.com/journal/JHA2 Article Preparation Support Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you c…
Source ↗Publisher website ·- Preprints
Preprint servers accepted. Model summary
This journal accepts articles previously published on preprint servers.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2688-6146
- Society / sponsor
- British Society for Haematology
- Latest issue on the website
- Volume 7, Issue 5 (October 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about eJHaem
What CAS zone is eJHaem in?
In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of eJHaem?
The journal's website gives an impact factor of 1.3 (2025); this is the journal's own figure, as LetPub lists none for it; h-index 23.
How long does peer review take at eJHaem?
Based on the dates recorded on 110 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 73 days (interquartile range 45–114 days); authors report an average review time of about 8 weeks; the journal's website gives an acceptance rate of 46% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of eJHaem based?
Of the 18 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United Kingdom (5), United States (2) and France (2). Counted from the institutions listed on the board page; for reference only.
Which databases index eJHaem?
According to LetPub and DOAJ records, eJHaem is indexed in ESCI and DOAJ. The journal's website also lists Web of Science, PMC, PubMed, Embase and CAS; that list has not been checked against each database.
Is eJHaem open access, and what is the APC?
eJHaem is a fully open-access journal. APC about USD 3,150.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .